NO165496C - Analogifremgangsmaate for fremstilling av nye epoksysteroider. - Google Patents

Analogifremgangsmaate for fremstilling av nye epoksysteroider.

Info

Publication number
NO165496C
NO165496C NO852501A NO852501A NO165496C NO 165496 C NO165496 C NO 165496C NO 852501 A NO852501 A NO 852501A NO 852501 A NO852501 A NO 852501A NO 165496 C NO165496 C NO 165496C
Authority
NO
Norway
Prior art keywords
cysteroids
preparation
new epoxy
analogue procedure
analogue
Prior art date
Application number
NO852501A
Other languages
English (en)
Norwegian (no)
Other versions
NO852501L (no
NO165496B (no
Inventor
Michel Biolaz
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of NO852501L publication Critical patent/NO852501L/no
Publication of NO165496B publication Critical patent/NO165496B/no
Publication of NO165496C publication Critical patent/NO165496C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0011—Androstane derivatives substituted in position 17 by a keto group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J13/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
    • C07J13/005—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17 with double bond in position 16 (17)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J21/005—Ketals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0053—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa not substituted in position 16
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C07J53/002—Carbocyclic rings fused
    • C07J53/004—3 membered carbocyclic rings
    • C07J53/008—3 membered carbocyclic rings in position 15/16
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/001—Oxiranes
    • C07J71/0015—Oxiranes at position 9(11)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO852501A 1984-06-21 1985-06-20 Analogifremgangsmaate for fremstilling av nye epoksysteroider. NO165496C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH300984 1984-06-21
CH464684 1984-09-28

Publications (3)

Publication Number Publication Date
NO852501L NO852501L (no) 1985-12-23
NO165496B NO165496B (no) 1990-11-12
NO165496C true NO165496C (no) 1991-02-20

Family

ID=25691934

Family Applications (1)

Application Number Title Priority Date Filing Date
NO852501A NO165496C (no) 1984-06-21 1985-06-20 Analogifremgangsmaate for fremstilling av nye epoksysteroider.

Country Status (16)

Country Link
US (1) US4670551A (enExample)
EP (1) EP0165902B1 (enExample)
AR (2) AR242036A1 (enExample)
AU (1) AU582754B2 (enExample)
CA (1) CA1239388A (enExample)
DE (1) DE3569540D1 (enExample)
DK (1) DK173854B1 (enExample)
ES (2) ES8704967A1 (enExample)
FI (1) FI83225C (enExample)
GR (1) GR851499B (enExample)
HU (1) HU192232B (enExample)
IE (1) IE58050B1 (enExample)
IL (1) IL75569A (enExample)
NO (1) NO165496C (enExample)
NZ (1) NZ212492A (enExample)
PT (1) PT80663B (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997021720A2 (en) 1995-12-11 1997-06-19 G.D. Searle And Co. Processes for preparation of 7 alpha-carboxyl 9,11-epoxy steroids and intermediates useful therein and a general process for the epoxidation of olifinic double bonds
NZ336004A (en) 1996-12-11 2001-04-27 G Process for preparation of 3-keto-7-alpha-alkoxycarbonyl substituted delta-4,5-steroid by reacting 4,5-dihydro-5,7-lactone steroid substrate in the presence of a base
EP1148061B1 (en) * 1996-12-11 2007-10-17 G.D. Searle LLC. Epoxidation process
US6887991B1 (en) 1996-12-11 2005-05-03 G. D. Searle & Company Processes for preparation of 9, 11-epoxy steroids and intermediates useful therein
US6372712B1 (en) 1998-05-22 2002-04-16 The Board Of Trustees Of The Leland Stanford Jr. University Synthetic bifunctional molecules containing a drug moiety and presenter protein ligand
WO2003049745A1 (en) 2001-12-12 2003-06-19 Pharmacia Corporation Method of treating ophthalmic disorders with epoxy-steroidal aldosterone receptor antagonists
US7235655B2 (en) 2002-03-22 2007-06-26 Pharmacia & Upjohn Company Processes to prepare eplerenone
EP2671508B1 (en) 2005-04-28 2020-09-16 Proteus Digital Health, Inc. Pharma-informatics system
WO2007025780A2 (en) * 2005-09-02 2007-03-08 Recordati Ireland Limited Aldosterone receptor antagonists
US9062126B2 (en) 2005-09-16 2015-06-23 Raptor Pharmaceuticals Inc. Compositions comprising receptor-associated protein (RAP) variants specific for CR-containing proteins and uses thereof
ES2919563T3 (es) 2009-02-20 2022-07-27 Enhanx Biopharm Inc Sistema de administración de medicamentos a base de glutatión
KR20180114970A (ko) 2009-05-06 2018-10-19 라보라토리 스킨 케어, 인크. 활성제-칼슘 포스페이트 입자 복합체를 포함하는 피부 전달 조성물 및 이들을 이용하는 방법

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3013012A (en) * 1960-12-22 1961-12-12 Searle & Co Alkanoylthio-17alpha-carboxyethyl-17beta-hydroxyandrosten-3-one lactones
US3095412A (en) * 1961-12-19 1963-06-25 Searle & Co 9alpha, 11alpha-epoxy and 11beta-chloro-9alpha-hydroxy 17alpha-(2-carboxyethyl)-17beta-hydroxyandrost-4-en-3-one gamma-lactones and delta1 and delta6 analogs
GB1041534A (en) * 1963-04-24 1966-09-07 Merck & Co Inc 20-spiroxane compounds
DE2652761C2 (de) * 1976-11-16 1985-11-21 Schering AG, 1000 Berlin und 4709 Bergkamen 15,16-Methylen-Spirolactone, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
US4559332A (en) * 1983-04-13 1985-12-17 Ciba Geigy Corporation 20-Spiroxanes and analogues having an open ring E, processes for their manufacture, and pharmaceutical preparations thereof
DE3481707D1 (de) * 1983-08-17 1990-04-26 Schering Ag 7-alpha-substituierte 3-oxo-17alpha-pregn-4-en-21.17-carbolactone, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate.

Also Published As

Publication number Publication date
NZ212492A (en) 1989-02-24
FI852430A0 (fi) 1985-06-19
AU582754B2 (en) 1989-04-13
DK173854B1 (da) 2001-12-27
DK280085A (da) 1985-12-22
AU4397185A (en) 1986-01-02
DK280085D0 (da) 1985-06-20
FI83225C (fi) 1991-06-10
IE58050B1 (en) 1993-06-16
PT80663A (en) 1985-07-01
EP0165902A3 (en) 1986-10-22
IL75569A (en) 1989-03-31
HUT38367A (en) 1986-05-28
US4670551A (en) 1987-06-02
EP0165902B1 (de) 1989-04-19
AR245731A1 (es) 1994-02-28
NO852501L (no) 1985-12-23
EP0165902A2 (de) 1985-12-27
IL75569A0 (en) 1985-10-31
ES8704967A1 (es) 1987-04-16
FI83225B (fi) 1991-02-28
FI852430L (fi) 1985-12-22
GR851499B (enExample) 1985-11-25
ES544387A0 (es) 1987-04-16
NO165496B (no) 1990-11-12
DE3569540D1 (en) 1989-05-24
ES8707737A1 (es) 1987-08-16
AR242036A1 (es) 1993-02-26
CA1239388A (en) 1988-07-19
HU192232B (en) 1987-05-28
IE851535L (en) 1985-12-21
ES557112A0 (es) 1987-08-16
PT80663B (en) 1987-05-08

Similar Documents

Publication Publication Date Title
NO871277L (no) Fremgangsmaate for fremstilling av nye oxadiazoler.
NO874764D0 (no) Fremgangsmaate for fremstilling av 2-aminopurinderivater.
NO873091L (no) Fremgangsmaate for fremstilling av nye benzimidazolderivater.
NO160444C (no) Analogifremgangsmaate for fremstilling av nye, terapeutiskaktive imidazo-pyrazolo-pyrimidiner.
NO904059D0 (no) Fremgangsmaate for fremstilling av nye substituerte isokinoliner.
NO171064C (no) Analogifremgangsmaate for fremstilling av aminoacyllabdaner
NO855067L (no) Fremgangsmaate for fremstilling av n-formyl-alfa-aspartyl-fenylalanin.
NO853066L (no) Fremgansmaate til fremstilling av 3-karbonyl-1-aminoalkyl-1h-indoler.
NO852501L (no) Nye epoksysteroider.
NO851310L (no) Stereospesifikk fremgangsmaate til fremstilling av acetonoksyazetidinon.
NO851920L (no) Fremgangsmaate for fremstilling av imidazo-rifamycin-derivater.
NO854577L (no) Fremgangsmaate for fremstilling av nye tienopyridinderivater.
NO166227C (no) Analogifremgangsmaate for fremstilling av nye antibakterielle pyrido-benzoksazin-6-karboksylsyrer.
NO165637C (no) Fremgangsmaate for fremstilling av etoksylert lignitt.
NO872393D0 (no) Fremgangsmaate for fremstilling av nye aralkylimidazolderivater.
NO874269D0 (no) Fremgangsmaate for fremstilling av epoksyharpikser.
NO161353C (no) Fremgangsmaate for fremstilling av pastiller.
NO166709C (no) Fremgangsmaate for fremstilling av akrylamider.
NO871721L (no) Fremgangsmaate for fremstilling av nye ergolenderivater.
FI852437L (fi) Anordning foer framstaellning av tomografiroentgenbilder.
NO864087L (no) Fremgangsmaate for fremstilling av aroylthiazoloner.
NO851319L (no) Fremgangsmaate for fremstilling av eburnanderivater.
NO884552L (no) Fremgangsmaate for fremstilling av epoksyharpikser.
NO851620L (no) Fremgangsmaate for fremstilling av nye bornan-derivater
NO903304D0 (no) Fremgangsmaate for fremstilling av 3-karbonyl-1-aminoalkyl-1h-indoler.